FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
暂无分享,去创建一个
P. Keegan | R. Pazdur | Martin H. Cohen | J. Gootenberg | P. Dinndorf | M. Cohen | Patricia Anne Dinndorf | Joseph Gootenberg